In a mouse model of Rett syndrome with loss of Mecp2, which acts upstream of CDKL5 to control its expression [85,86], there is marked dysregulation of miRNA levels including miR-215, miR-375, and miR-101 [83], which were dysregulated in our CDD mice. Here, MECP2 is linked to craniodiaphyseal dysplasia.